Cancer- The breaking news on the treatment, cure and diagnosis of cancer

 
 

 
 

  • Search for "cancer news"
  • Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand

    Interview with Mesothelioma Experts, Drs. Simone and Alley Now Available on Demand
    The interview with Dr. Charles Simone and Dr. Evan Alley both of the University of Pennsylvania Medicine, which was broadcast live on Thursday, May 14, by the Mesothelioma Applied Research Foundation, is now available on demand on the Foundation's website. On Thursday, May 14, the Mesothelioma Applied Research Foundation interviewed Dr. Charles Simone and Dr. Evan Alley both of the University of Pennsylvania Medicine, during its 'Meet the Mesothelioma Experts' series.
  • My 70's memories

    My 70's memories
    During 1970s was when the peak of my life is. Lots of things happened - good, bad, happy, sad - very seasonal, it is! But regardless of what emotions it brought me, it was still very remarkable.
  • Where's the Best Place to Breastfeed Your Baby?

    Where's the Best Place to Breastfeed Your Baby?
    Now that moms can breastfeed their infants in public without fear of discrimination or being sent to a public restroom to feed the babies, an Oakland County group wants to publicly recognize local businesses, employers and others who are taking extraordinary steps to accommodate the moms. Nominations for the Breastfeeding-Friendly Place Awards will be accepted until 5 p.m. Friday, June 3, by the Oakland County Breastfeeding Coalition, which is sponsoring the competition in collaboration with the Oakland County Health Division Women, Infants and Children program.
  • Calender project reinforces the need for prostate cancer checks

    Calender project reinforces the need for prostate cancer checks
    Congratulations, you're now registered! Let us know what news and updates you want to hear about and we'll send them straight to your inbox. A saucy seaside calendar launched by a prostate cancer survivor to raise awareness of the disease has proved to be a huge success.
  • XOMA: Phase 3 EYEGUARD-B Trial Is Good News For Gevokizumab

    XOMA: Phase 3 EYEGUARD-B Trial Is Good News For Gevokizumab
    XOMA announced good news from Phase 3 EYEGUARD-B trial of its monoclonal antibody drug gevokizumab for Behcet's uveitis. The study, which is sponsored by XOMA's development partner Servier, reached its target exacerbation event as specified in the study design.
  • Biocompare Cancer
  • Tilted Acoustic Tweezers Separate Cells Gently

    Tilted Acoustic Tweezers Separate Cells Gently
    Precise, gentle and efficient cell separation from a device the size of a cell phone may be possible thanks to tilt-angle standing surface acoustic waves, according to a team of engineers.
  • New Biomarker Highly Promising For Predicting Breast Cancer Outcomes

    New Biomarker Highly Promising For Predicting Breast Cancer Outcomes
    A protein named p66ShcA shows promise as a biomarker to identify breast cancers with poor prognoses, according to research published ahead of print in the journal Molecular and Cellular Biology.
  • Finding Keys To Glioblastoma Therapeutic Resistance

    Finding Keys To Glioblastoma Therapeutic Resistance
    Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas - the primary form of a deadly brain cancer - are resistant to drug therapy. The answer lies not in the DNA sequence of the tumor, but in its epigenetic signature. These findings have been published online as a priority report in the journal Oncotarget.
  • Mimicking Natural Evolution With 'promiscuous Reactions' To Improve The Diversity Of Drugs

    Mimicking Natural Evolution With 'promiscuous Reactions' To Improve The Diversity Of Drugs
    A revolutionary new scientific method developed at the University of Leeds will improve the diversity of 'biologically active molecules', such as antibiotics and anti-cancer agents.
  • Study Suggests Repurposing Anti-Depressant Medication To Target Medulloblastoma

    Study Suggests Repurposing Anti-Depressant Medication To Target Medulloblastoma
    CINCINNATI - An international research team reports in Nature Medicine a novel molecular pathway that causes an aggressive form of medulloblastoma, and suggests repurposing an anti-depressant medication to target the new pathway may help combat one of the most common brain cancers in children.